These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 26072926)
21. Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy. Su X; Lin R; Huang Y; Sheng H; Li X; Ting TH; Liu L; Li X J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):52-57. PubMed ID: 27612026 [TBL] [Abstract][Full Text] [Related]
22. Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4. Nilay Güneş ; Kutlu T; Tekant GT; Eroğlu AG; Üstündağ NÇ; Öztürk B; Onay H; Tüysüz B Eur J Med Genet; 2020 Apr; 63(4):103819. PubMed ID: 31778856 [TBL] [Abstract][Full Text] [Related]
23. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786 [TBL] [Abstract][Full Text] [Related]
24. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263 [TBL] [Abstract][Full Text] [Related]
28. Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations. Shastry S; Delgado MR; Dirik E; Turkmen M; Agarwal AK; Garg A Am J Med Genet A; 2010 Sep; 152A(9):2245-53. PubMed ID: 20684003 [TBL] [Abstract][Full Text] [Related]
29. A Patient with Berardinelli-Seip Syndrome, Novel Oswiecimska J; Dawidziuk M; Gambin T; Ziora K; Marek M; Rzonca S; Guilbride DL; Jhangiani SN; Obuchowicz A; Sikora A; Lupski JR; Wiszniewski W; Gawlinski P J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):319-326. PubMed ID: 30563316 [TBL] [Abstract][Full Text] [Related]
30. Determining residual adipose tissue characteristics with MRI in patients with various subtypes of lipodystrophy. Altay C; Seçil M; Demir T; Atik T; Akıncı G; Özdemir Kutbay N; Keskin Temeloğlu E; Yıldırım Şimşir I; Özışık S; Demir L; Eren E; Tuna EB; Aytaç H; Onay H; Akıncı B Diagn Interv Radiol; 2017; 23(6):428-434. PubMed ID: 29044029 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2. Freire EBL; Brasil d'Alva C; Madeira MP; Lima GEDCP; Fernandes VO; Aguiar LB; Portella LB; Galvão Ozório R; Ponte CMM; Montenegro APDR; Montenegro Junior RM Front Endocrinol (Lausanne); 2024; 15():1326700. PubMed ID: 38633760 [TBL] [Abstract][Full Text] [Related]
32. Bone imaging findings in genetic and acquired lipodystrophic syndromes: an imaging study of 24 cases. Teboul-Coré S; Rey-Jouvin C; Miquel A; Vatier C; Capeau J; Robert JJ; Pham T; Lascols O; Berenbaum F; Laredo JD; Vigouroux C; Sellam J Skeletal Radiol; 2016 Nov; 45(11):1495-506. PubMed ID: 27631079 [TBL] [Abstract][Full Text] [Related]
33. Pathology of congenital generalized lipodystrophy in Agpat2-/- mice. Vogel P; Read R; Hansen G; Wingert J; Dacosta CM; Buhring LM; Shadoan M Vet Pathol; 2011 May; 48(3):642-54. PubMed ID: 21051554 [TBL] [Abstract][Full Text] [Related]
34. Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO. da Cunha Olegario NB; da Cunha Neto JS; Barbosa PCS; Pinheiro PR; Landim PLA; Montenegro APDR; Fernandes VO; de Albuquerque VHC; Duarte JBF; da Cruz Paiva Lima GE; Junior RMM Sci Rep; 2023 Feb; 13(1):2176. PubMed ID: 36750605 [TBL] [Abstract][Full Text] [Related]
35. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations. Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546 [TBL] [Abstract][Full Text] [Related]
37. SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophy. Madeira MP; Freire EBL; Fernandes VO; Lima GEDCP; Melo IDP; Montenegro APDR; Freire JEDC; Moreira-Nunes CFA; Montenegro RC; Colares JKB; Montenegro Junior RM; Diabetol Metab Syndr; 2021 Jun; 13(1):65. PubMed ID: 34130736 [TBL] [Abstract][Full Text] [Related]
38. [Unusual facies and recurrent high triglycerides for more than one year in a girl]. Yin ZX; He XL; Zou RY Zhongguo Dang Dai Er Ke Za Zhi; 2018 Dec; 20(12):1050-1054. PubMed ID: 30572997 [TBL] [Abstract][Full Text] [Related]
39. Ablation of Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133 [TBL] [Abstract][Full Text] [Related]
40. Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X Sorkina E; Makarova P; Bolotskaya L; Ulyanova I; Chernova T; Tiulpakov A Clin Diabetes Endocrinol; 2020; 6():7. PubMed ID: 32467771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]